copper tripeptide raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-08-30. Anything still debated is marked as such rather than presented as settled.
Published studies describe the complex in several research contexts, including collagen synthesis, antioxidant behaviour, and wound repair models. Much of this work is conducted in cultured cells or in small animal systems, and the findings are frequently cited in reviews of copper peptides. Direct clinical evidence in humans is comparatively limited, and reported outcomes vary with formulation and study design. Whether free chain or metal-bound form was used is not always stated, a point that complicates comparison between reports.
GHK-Cu is a coordination complex formed between the peptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The unbound chain, abbreviated GHK, consists of three amino acids and occurs naturally in human plasma, saliva, and urine. Binding of the metal is mediated mainly by the imidazole nitrogen of the histidine residue together with backbone amides, producing a stable chelate. Ingredient nomenclature often lists the same substance as copper tripeptide-1. Its charge and solubility behaviour differ from those of the metal-free chain.
The copper-binding activity of this sequence was described in the 1970s during studies of liver tissue and plasma factors. Early work identified the peptide as a component that influenced copper uptake by cells and that appeared in wound fluid. Later investigations examined its presence across species, reporting the same chain in human and animal samples. A decline in measured concentration with age became a recurring observation, although the underlying causes remain incompletely characterised.
Copper content is measured separately, since a peptide assay alone does not report the metal-to-peptide ratio. Elemental techniques such as inductively coupled plasma optical emission spectroscopy quantify copper after acid digestion of the sample. The result is compared with the theoretical value for a one-to-one complex, and a shortfall indicates free peptide or partial dissociation. Suppliers differ in how they state purity, as some quote peptide content and others quote the whole complex. A defined stoichiometry therefore requires both a peptide assay and a copper assay.
Solid GHK-Cu is usually supplied as a lyophilized powder and is kept cold and dry. Moisture, light, and repeated temperature cycling shorten its useful life in the laboratory. In aqueous solution the complex undergoes slow hydrolysis of the peptide backbone and gradual loss of coordinated copper. Buffers containing strong chelators, such as EDTA, compete for the metal and strip it from the peptide. Working solutions are therefore prepared shortly before use, and leftover liquid is not returned to the stock container.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Copper(II) peptide complex | Coordination compound rather than a simple salt |
| Peptide sequence | Glycyl-L-histidyl-L-lysine | Abbreviated GHK in most literature |
| Molecular formula | C14H22N6O4Cu | Reported for the 1:1 complex |
| Principal binding site | Histidine imidazole nitrogen | Backbone amides contribute additional coordination |
| Common synonym | Copper tripeptide-1 | Used in ingredient and product labelling |
Material described as GHK-Cu appears in several distinct markets, including cosmetic ingredients, laboratory reagents, and consumer products, and the quality expectations attached to each differ. A certificate of analysis generally reports peptide purity by chromatography, copper content, appearance, and residual solvents or counterions. Counterion identity matters, because the complex is usually supplied as an acetate or a similar salt, and the counterion contributes to the measured mass. Independent verification of sequence and metal stoichiometry is advisable when a material is used for quantitative work. Batch-to-batch variation is common and should be documented rather than assumed negligible.
Copper peptide solutions tend to resist degradation better than many free peptides, because the bound metal protects the N-terminus and reduces susceptibility to some peptidases. Backbone hydrolysis, oxidation of the histidine imidazole ring, and photochemical reactions remain the principal degradation routes. Aqueous solutions are generally most stable near neutral to mildly acidic pH, while strongly alkaline conditions accelerate hydrolysis. Light exposure is usually avoided, since both the peptide and the copper center can take part in photochemical processes. Stability data published by suppliers often describe short-term behavior rather than multi-year shelf life.
Identity and purity are commonly assessed by reversed-phase high-performance liquid chromatography, frequently paired with mass spectrometry to confirm the molecular ion. Copper content is measured separately, typically by inductively coupled plasma mass spectrometry or atomic absorption spectroscopy, because the chromatographic signal reports the peptide rather than the metal. Ultraviolet-visible spectroscopy provides a fast check on complex formation, since copper(II) peptide complexes absorb in the visible region. Elemental analysis and amino acid analysis are used less often but remain useful for reference standards. A gap between reported peptide purity and measured copper content is a recurring source of confusion.
Copper binds to the peptide through the histidine imidazole nitrogen and the terminal amino group, forming a stable square-planar complex. Binding constants reported for copper(II) with GHK are high, so the peptide competes effectively for copper in solution. The complex absorbs visible light, which gives solutions a blue to violet colour. Whether the metal-free peptide has a distinct biological function of its own is still an open question; some work treats it mainly as a copper delivery vehicle, while other work reports peptide-specific effects.
The compound was first isolated from human plasma in the 1970s by Loren Pickart, who later described copper-binding activity in liver and other tissues. Early reports focused on its presence in blood and its ability to carry copper between proteins. Commercial and cosmetic use of the term 'copper peptide' has since broadened, and labels rarely distinguish GHK-Cu from other copper-binding fragments. This naming overlap makes literature searching harder, because cosmetic ingredient lists, supplier catalogues and laboratory papers use different vocabularies for the same molecule.
GHK-Cu is the copper-binding complex formed by the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The free peptide is usually written as GHK, and the complex is written as GHK-Cu or Cu-GHK. The sequence was identified in human plasma and later detected in saliva and urine. Its name comes from the single-letter codes of glycine, histidine and lysine. The complex is widely described as a naturally occurring carrier of copper in blood rather than as a free peptide with its own hormonal role.
=== Other incidents === On 13 September 1999, six people tried to steal 60Co rods from a chemical plant in the city of Grozny, Chechen Republic, Russia. During the theft, the suspects opened the radioactive material container and handled it, resulting in the deaths of three of the suspects and injury of the remaining three. The suspect who held the material directly in his hands died of radiation exposure 30 minutes later. This incident is described as an attempted theft, but some of the rods are reportedly still missing.
==== Third tour 21 April to 3 June 1953 ==== In April 1953, Thomas returned alone for a third tour of America. He performed a "work in progress" version of Under Milk Wood, solo, for the first time at Harvard University on 3 May. A week later, the work was performed with a full cast at the Poetry Centre in New York. He met the deadline only after being locked in a room by Brinnin's assistant, Liz Reitell, and he was still editing the script on the afternoon of the performance; its last lines were handed to the actors as they were putting on their makeup. During this penultimate tour, Thomas met the composer Igor Stravinsky who had become an admirer after having been introduced to his poetry by W. H. Auden. They had discussions about collaborating on a "musical theatrical work" for which Thomas would provide the libretto on the theme of "the rediscovery of love and language in what might be left after the world after the bomb." The letters Stravinsky sent to Thomas during this period testify not only to the composer's sustained interest in bringing the projected opera to fruition but also to the friendship and affection that developed between them, which in turn fueled their shared excitement about a project they envisioned as both artistically ambitious and urgently attuned to the anxieties of their time.(The Opera that Never Was) The shock of Thomas's death later in the year moved Stravinsky to compose his In Memoriam Dylan Thomas for tenor, string quartet and four trombones.
Hyperthyroidism is one of the most common endocrine conditions affecting older domesticated housecats. In the United States, up to 10% of cats over ten years old have hyperthyroidism. The disease has become significantly more common since the first reports of feline hyperthyroidism in the 1970s. The most common cause of hyperthyroidism in cats is the presence of benign tumors called adenomas. Adenomas cause 98% of cases, but the reason these cats develop such tumors remains under study. The most common presenting symptoms are: rapid weight loss, tachycardia (rapid heart rate), vomiting, diarrhea, increased consumption of fluids (polydipsia), increased appetite (polyphagia), and increased urine production (polyuria). Other symptoms include hyperactivity, possible aggression, an unkempt appearance, and large, thick claws. Heart murmurs and a gallop rhythm can develop due to secondary hypertrophic cardiomyopathy. About 70% of affected cats also have enlarged thyroid glands (goiter). The same three treatments used with humans are also options in treating feline hyperthyroidism (surgery, radioiodine treatment, and anti-thyroid drugs). There is also a special low-iodine diet available that will control symptoms, provided no other food is fed; Hill's y/d formula, when given exclusively, decreases T4 production by limiting the amount of iodine needed for thyroid hormone production. It is the only available commercial diet that focuses on managing feline hyperthyroidism.
== See also == Biological Stain Commission: Third-party quality control and certification of stains Cytology: the study of cells Histology: the study of tissues Immunohistochemistry: the use of antisera to label specific antigens Ruthenium(II) tris(bathophenanthroline disulfonate), a protein dye. Vital stain: stains that do not kill cells PAGE: separation of protein molecules Barium enema - a type of in vivo stain that creates contrast in the x-ray part of the light spectrum Diaphonization
International Journal of Pharmaceutics Volume 215 Issue 1-2 Pages 45–50 (2001) Chromatography: Separation and Indirect Detection of Amino-acids by Reversed Phase ion-pair Chromatography. Journal of Chromatographic Science Volume 31 Issue 11 Pages 480-485 (1993) Determination of pore/protein size via electrophoresis and slit sieve model. Electrophoresis Volume 25 Issue 17 Pages 2907-2911 (2004)
Sources: en.wikipedia.org
Ames (1937), philanthropist, banker at Lazard Freres John Kluge (1937), billionaire, chairman and founder of Metromedia; America's richest person from 1989 to 1990; namesake of the John W. Kluge Center and Kluge Prize at the Library of Congress Vincent Sardi Jr.* (1937), restaurateur, owner of Sardi's, son of Vincent Sardi, Sr. Fred D. Thompson (1937), president and chief executive of Family Circle, vice president of The New York Times Grover Connell (1939), rice trader known for political campaign contributions Howard Pack (1939), chairman and president of Seatrain Lines Daniel Edelman (1940), founder of the world's largest public relations firm Edelman Elliott Sanger (1943), co-founder of classical radio channel WQXR-FM and advocate of FM broadcasting Wylie F. L. Tuttle (1944), real estate developer who spearheaded the construction of Tour Montparnasse Robert Rosencrans (1949), founding chairman of C-SPAN and president of UA-Columbia Cablevision Norton Garfinkle (1951), economist, businessman, public servant; chairman of the Future of American Democracy Foundation Mark N. Kaplan (1951), CEO of Drexel Burnham Lambert and Engelhard Harvey M. Krueger (1951), CEO of Kuhn, Loeb & Co. and vice chairman of Lehman Brothers Alan Wagner (1951), first president of Disney Channel Roone Arledge (1952), former president of ABC News and winner of 36 Emmys; creator of 20/20, Nightline, Monday Night Football, ABC World News Tonight and Primetime Alan N.
In June 1998, Caldwell Dyson was selected by NASA, and began NASA training two months later, in August 1998. Her astronaut candidate training included orientation briefings and tours, numerous scientific and technical briefings, intensive instruction in Shuttle and International Space Station (ISS) systems, physiological training, ground school to prepare for T-38 flight training, as well as learning water and wilderness survival techniques. Completion of this training and evaluation qualified her for flight assignment as a mission specialist. In 1999, Caldwell Dyson was assigned to the Astronaut Office ISS Operations Branch as a Russian Crusader, participating in the testing and integration of Russian hardware and software products developed for ISS. In 2000, she was assigned prime crew support astronaut for the ISS Expedition 5 crew, serving as their representative on technical and operational issues throughout the training and on-orbit phase of their mission. During ISS Expeditions 4 through 6, Caldwell Dyson served as an ISS spacecraft communicator (CAPCOM) inside Mission Control. In 2003, she made a transition to the Astronaut Shuttle Operations Branch and was assigned to flight software verification in the Shuttle Avionics Integration Laboratory and worked supporting launch and landing operations at Kennedy Space Center, Florida. Caldwell Dyson also served as Lead CAPCOM for Expedition 11.
Qingzhou (Chinese: 轻舟货运飞船; pinyin: Qīngzhōu huòyùn fēichuán) is a class of cargo spacecraft developed by CAS Space, a company founded by the Chinese Academy of Sciences. It is part of the China Manned Space Program's low-cost cargo transportation system designed to support the Tiangong space station. A prototype version of the Qingzhou spacecraft was successfully launched as the primary payload of the maiden flight of the Kinetica-2 (Lijian-2) rocket on 30 March 2026. The first production-standard spacecraft is expected to be ready for flight by late 2026.
=== Segmental vitiligo === SV differs in appearance, cause, and frequency of associated illnesses. It tends to affect areas of skin that are associated with dorsal roots from the spinal cord, is most often unilateral (affecting only one side of the body), tends to occur in youth, and stabilizes after a couple of years' progression. An autoimmune link, once believed not to characterize SV, has been discovered in recent research. SV is highly resistant to medical treatment. Surgeries such as cellular grafting can be effective, but not while the disorder is active.
=== Differential diagnosis === Cervical radiculopathy can also cause paresthesia and abnormal sensibility in the hands and wrist. The distribution usually follows the nerve root, and the paresthesia may be provoked by neck movement. Electromyography and imaging of the cervical spine can help to differentiate cervical radiculopathy from carpal tunnel syndrome if the diagnosis is unclear. Carpal tunnel syndrome is sometimes applied as a label to anyone with pain, numbness, swelling, or burning in the radial side of the hands or wrists. When pain is the primary symptom, carpal tunnel syndrome is unlikely to be the source of the symptoms. When the symptoms and signs point to atrophy and muscle weakness more than numbness, consider neurodegenerative disorders such as Amyotrophic Lateral Sclerosis or Charcot-Marie Tooth.
Sources: en.wikipedia.org
GHK denotes the unbound chain of three amino acids. GHK-Cu describes the form in which a copper(II) ion is held by that chain. The two are not interchangeable in solution, since charge, molecular weight, and reactivity differ.
The chain occurs in human plasma, saliva, and urine. Measured amounts are reported to fall with age. Copper binding by the sequence is treated as part of normal metal handling in tissue.
The bound copper(II) centre contributes to redox behaviour and to stability under physiological conditions. Free copper ions can participate in reactions that generate reactive species, while chelated metal is generally more controlled. The chain may also serve as a carrier for copper in experimental systems.
Lyophilized material is normally held at about minus twenty degrees Celsius in a sealed, desiccated vial. Dissolved samples are less durable and are prepared fresh. Repeated freeze-thaw cycles are avoided.